Gut microbiome composition and metabolite profiles have previously been linked to both colorectal tumorigenesis and immune checkpoint inhibitor responsiveness. Now, Lobel et al. identify sulfur amino acid metabolism as a microorganism-derived metabolic pathway that enhances anti-tumour immunity.